The Medical Research Council and GATC Biotech sign Sequencing Contract
The Medical Research Council (MRC) and GATC Biotech have signed a mutual contract relating to the provision of services for DNA sequencing. GATC Biotech is a tender winner selected from over ten participating suppliers for the MRC sequencing contract, valued at nearly 2.5 million Euros. A key selling point for the company was its fully automated sequencing process that reduced the level of human intervention and error, thereby achieving the highest possible accuracy of sequence data. GATC will provide MRC's 35 UK sites with high quality sequencing services for at least a three year period.
"Due to our proprietary LIMS we are able to customise the paperless order process precisely to the MRC's needs. This is a great benefit as we incorporate their administrative requirements, too," says Tony Piper, General Manager of GATC Biotech Ltd.
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.